These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2546480)

  • 21. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semiquantitation of cannabinoid immunoassays? A reexamination of the EMIT 20-ng/mL assay.
    Haver VM; Romson JL; Sadrzadeh SM
    J Anal Toxicol; 1991; 15(2):98-100. PubMed ID: 1646909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
    Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR
    J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of a detection level of 25ng/mL for cannabinoids in urine using a CEDIA THCPLUS immunoassay: application of this cut-off to urines of school children.
    Madhavaram H; Couch RA
    Forensic Sci Int; 2010 May; 198(1-3):28-30. PubMed ID: 20219301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.
    Wolf CE; Pokhai AA; Poklis JL; Williams GR
    J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates.
    Karlsson L; Ström M
    J Anal Toxicol; 1988; 12(6):319-21. PubMed ID: 3072448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of cannabinoids in urine: a cost-effective low risk immunoassay procedure.
    Moore FM; Simpson D
    Med Lab Sci; 1991 Jan; 48(1):76-9. PubMed ID: 1905775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary screening for alpha-OH triazolam by FPIA and EIA with confirmation by GC/MS.
    Fraser AD; Bryan W; Isner AF
    J Anal Toxicol; 1992; 16(6):347-50. PubMed ID: 1293398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
    McBurney LJ; Bobbie BA; Sepp LA
    J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of TDx cocaine metabolite assay.
    Poklis A
    J Anal Toxicol; 1987; 11(5):228-30. PubMed ID: 3682784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and quantitation of cannabinoids in biological fluids: specificity and kinetics after smoking.
    Scherrmann JM; Hoellinger H; Nguyen-Hoang-Nam ; Boudet L; Pichon J; Do-Cao-Thang
    Clin Toxicol; 1981 May; 18(5):565-71. PubMed ID: 6268351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass screening and confirmation of diazepam in urine by EMIT-thin-layer chromatography.
    Budd RD; Walkin E
    Clin Toxicol; 1980 Apr; 16(2):201-7. PubMed ID: 6994998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marihuana metabolites in urine of man. VII. Excretion patterns of acidic metabolites detected by sequential thin layer chromatography.
    Kanter SL; Hollister LE
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):421-31. PubMed ID: 897336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS; Pearlman R; Tsilimidos M; Salamone SJ; Cannon RC; Wong SH; Gock SB; Jentzen JJ
    J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.